Get the latest Science News and Discoveries

NRG Oncology trial results show no survival benefit with the use of proton therapy for patients with advanced hepatocellular carcinoma

None

Related news:

Shortened radiation schedule provides similar cancer control and patient-reported outcomes to standard radiation following surgery for high-risk prostate cancer in NRG Oncology trial

NRG Oncology SPPORT analysis highlights potential role of genetic testing in identifying prostate cancer patients who may benefit most from hormone therapy

Up to one in three people with type 2 diabetes develop serious heart or kidney disease or die within five years of diagnosis, study of 1.6 million patients suggests

« NRG Oncology Trial Finds No Difference in NeurocoNRG Oncology trial finds no difference in neurocognitive outcomes, but improved overall survival with stereotactic radiosurgery for SCLC brain metastases

Heredity is about more than just DNA »